Search research articles
Contact Us
Filters
Showing results (71-80 of 666) with videos related to
Page
of 67
Sort By:
Journal of the American Academy of Child Psychiatry
|
January 1, 1979
Triaxial family classification: a proposal
W S Tseng, J F McDermott
Cancer Treatment Reviews
|
February 2, 2010
Bevacizumab as a treatment option in advanced renal cell carcinoma: an analysis and interpretation of clinical trial data
David F McDermott, Daniel J George
Cancer Medicine
|
January 10, 2014
PD-1 as a potential target in cancer therapy
David F McDermott, Michael B Atkins
Cytokine & Growth Factor Reviews
|
August 30, 2014
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future
Lisa M Sedger, Michael F McDermott
Journal of the American Academy of Child Psychiatry
|
January 1, 1976
The treatment of child abuse. Play therapy with a 4-year-old child
P A In, J F McDermott
Journal for Immunotherapy of Cancer
|
August 27, 2025
How can we increase the value of clinical trials with immunotherapy?
Michael B Atkins, David F Mcdermott
Journal of the American Academy of Child and Adolescent Psychiatry
|
June 24, 2004
Formulation: putting the diagnosis into a therapeutic context and treatment plan
Michael S Jellinek, John F McDermott
Nature Clinical Practice. Rheumatology
|
November 19, 2008
Rilonacept in cryopyrin-associated periodic syndromes: the beginning of longer-acting interleukin-1 antagonism
Leigh D Church, Michael F McDermott
Academic Medicine : Journal of the Association of American Medical Colleges
|
December 11, 1991
Retraining faculty for the problem-based curriculum at the University of Hawaii, 1989-1991
J F McDermott, A S Anderson
Clinical Therapeutics
|
March 10, 2015
Cytotoxic T-lymphocyte antigen-4 blockade in melanoma
Elizabeth I Buchbinder, David F McDermott
Page
of 67
Search research articles
Search
Showing results (71-80 of 666) with videos related to
Sort By:
Page
of 67
Journal of the American Academy of Child Psychiatry
|
January 1, 1979
Triaxial family classification: a proposal
W S Tseng, J F McDermott
Cancer Treatment Reviews
|
February 2, 2010
Bevacizumab as a treatment option in advanced renal cell carcinoma: an analysis and interpretation of clinical trial data
David F McDermott, Daniel J George
Cancer Medicine
|
January 10, 2014
PD-1 as a potential target in cancer therapy
David F McDermott, Michael B Atkins
Cytokine & Growth Factor Reviews
|
August 30, 2014
TNF and TNF-receptors: From mediators of cell death and inflammation to therapeutic giants - past, present and future
Lisa M Sedger, Michael F McDermott
Journal of the American Academy of Child Psychiatry
|
January 1, 1976
The treatment of child abuse. Play therapy with a 4-year-old child
P A In, J F McDermott
Journal for Immunotherapy of Cancer
|
August 27, 2025
How can we increase the value of clinical trials with immunotherapy?
Michael B Atkins, David F Mcdermott
Journal of the American Academy of Child and Adolescent Psychiatry
|
June 24, 2004
Formulation: putting the diagnosis into a therapeutic context and treatment plan
Michael S Jellinek, John F McDermott
Nature Clinical Practice. Rheumatology
|
November 19, 2008
Rilonacept in cryopyrin-associated periodic syndromes: the beginning of longer-acting interleukin-1 antagonism
Leigh D Church, Michael F McDermott
Academic Medicine : Journal of the Association of American Medical Colleges
|
December 11, 1991
Retraining faculty for the problem-based curriculum at the University of Hawaii, 1989-1991
J F McDermott, A S Anderson
Clinical Therapeutics
|
March 10, 2015
Cytotoxic T-lymphocyte antigen-4 blockade in melanoma
Elizabeth I Buchbinder, David F McDermott
Page
of 67